标题
Cells of Matter—In Vitro Models for Myotonic Dystrophy
作者
关键词
-
出版物
Frontiers in Neurology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-05-23
DOI
10.3389/fneur.2018.00361
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lymphoblastoids cell lines – Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG) 200 expansion in the DMPK gene: CHUQi001-A
- (2018) Laurie Martineau et al. Stem Cell Research
- Generation of Neural Cells from DM1 Induced Pluripotent Stem Cells As Cellular Model for the Study of Central Nervous System Neuropathogenesis
- (2018) Guangbin Xia et al. Cellular Reprogramming
- Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9
- (2017) Belinda S. Pinto et al. MOLECULAR CELL
- CRISPR/Cas9-Induced (CTG⋅CAG) n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
- (2017) Ellen L. van Agtmaal et al. MOLECULAR THERAPY
- Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
- (2017) Laura Valentina Renna et al. PLoS One
- Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
- (2017) Dominic Jauvin et al. Molecular Therapy-Nucleic Acids
- CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients
- (2017) Claudia Provenzano et al. Molecular Therapy-Nucleic Acids
- Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
- (2017) Junko Ueki et al. Scientific Reports
- Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts
- (2016) Boris Pantic et al. EXPERIMENTAL CELL RESEARCH
- Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy
- (2016) Yuanzheng Gao et al. MOLECULAR THERAPY
- Derivation of DM1 affected human embryonic stem cell line Genea067
- (2016) Biljana Dumevska et al. Stem Cell Research
- Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
- (2016) Fernande Freyermuth et al. Nature Communications
- Dynamic changes of nuclear RNA foci in proliferating DM1 cells
- (2015) Guangbin Xia et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models
- (2015) Ruth B. Siboni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
- (2015) Agnieszka Wojtkowiak-Szlachcic et al. NUCLEIC ACIDS RESEARCH
- Genome Modification Leads to Phenotype Reversal in Human Myotonic Dystrophy Type 1 Induced Pluripotent Stem Cell-Derived Neural Stem Cells
- (2015) Guangbin Xia et al. STEM CELLS
- Abnormal splicing switch of DMD’s penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
- (2015) Frédérique Rau et al. Nature Communications
- In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin
- (2015) Delphine Laustriat et al. Molecular Therapy-Nucleic Acids
- Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells
- (2015) Shira Yanovsky-Dagan World Journal of Stem Cells
- Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease
- (2014) Ranjan Batra et al. MOLECULAR CELL
- Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects
- (2014) Jason W. Hoskins et al. NUCLEIC ACIDS RESEARCH
- MBNL proteins and their target RNAs, interaction and splicing regulation
- (2014) Patryk Konieczny et al. NUCLEIC ACIDS RESEARCH
- Reducing Levels of Toxic RNA with Small Molecules
- (2013) Leslie A. Coonrod et al. ACS Chemical Biology
- Splicing biomarkers of disease severity in myotonic dystrophy
- (2013) Masayuki Nakamori et al. ANNALS OF NEUROLOGY
- Length-dependent CTG{middle dot}CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells
- (2013) J. Du et al. HUMAN MOLECULAR GENETICS
- High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines
- (2013) Ami Ketley et al. HUMAN MOLECULAR GENETICS
- mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1
- (2013) J. A. Denis et al. JOURNAL OF CELL SCIENCE
- MBNL1 42 and MBNL1 43 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
- (2013) A Botta et al. Cell Death & Disease
- Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
- (2013) Anchel González-Barriga et al. Molecular Therapy-Nucleic Acids
- Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA that Causes Myotonic Dystrophy Type 1
- (2012) Jessica L. Childs-Disney et al. ACS Chemical Biology
- The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing
- (2012) Aymeric Ravel-Chapuis et al. JOURNAL OF CELL BIOLOGY
- RNA Interference Targeting CUG Repeats in a Mouse Model of Myotonic Dystrophy
- (2012) Krzysztof Sobczak et al. MOLECULAR THERAPY
- RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1
- (2012) J. E. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative splicing regulation by Muscleblind proteins: from development to disease
- (2011) Juan M. Fernandez-Costa et al. BIOLOGICAL REVIEWS
- Mutant Human Embryonic Stem Cells Reveal Neurite and Synapse Formation Defects in Type 1 Myotonic Dystrophy
- (2011) Antoine Marteyn et al. Cell Stem Cell
- Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies
- (2011) R Cardani et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study
- (2011) F. Perdoni et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential
- (2011) K Shiomi et al. GENE THERAPY
- Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of CaV1.1 calcium channel
- (2011) Zhen Zhi Tang et al. HUMAN MOLECULAR GENETICS
- Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
- (2011) Charlotte Fugier et al. NATURE MEDICINE
- Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy
- (2011) Frédérique Rau et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy
- (2011) Daniel Beaulieu et al. NEUROBIOLOGY OF DISEASE
- Constructing and Deconstructing Stem Cell Models of Neurological Disease
- (2011) Steve S.W. Han et al. NEURON
- Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders
- (2011) Kamel Mamchaoui et al. Skeletal Muscle
- Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells
- (2010) E Loro et al. CELL DEATH AND DIFFERENTIATION
- Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells
- (2010) Claudia Huichalaf et al. FASEB JOURNAL
- Bidirectional transcription stimulates expansion and contraction of expanded (CTG)•(CAG) repeats
- (2010) Masayuki Nakamori et al. HUMAN MOLECULAR GENETICS
- Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
- (2010) Virginie François et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy
- (2010) Hongqing Du et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Large CTG Repeats Trigger p16-Dependent Premature Senescence in Myotonic Dystrophy Type 1 Muscle Precursor Cells
- (2009) Anne Bigot et al. AMERICAN JOURNAL OF PATHOLOGY
- Rational Design of Ligands Targeting Triplet Repeating Transcripts That Cause RNA Dominant Disease: Application to Myotonic Muscular Dystrophy Type 1 and Spinocerebellar Ataxia Type 3
- (2009) Alexei Pushechnikov et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Pentamidine reverses the splicing defects associated with myotonic dystrophy
- (2009) M. B. Warf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
- (2009) S. A. M. Mulders et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation
- (2008) N. De Temmerman et al. MOLECULAR HUMAN REPRODUCTION
- Aberrantly spliced -dystrobrevin alters -syntrophin binding in myotonic dystrophy type 1
- (2008) M. Nakamori et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started